JCR Pharmaceuticals Co (FRA:JCR) Cyclically Adjusted Book per Share: €1.90 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:JCR JCR Pharmaceuticals Co Ltd FRA:JCR
47 GF Score
Price €2.78
GF Value €4.19
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Cyclically Adjusted Book per Share?

JCR Pharmaceuticals Co FRA:JCR +2.21% 47 Cyclically Adjusted Book per Share is €1.90 as of Mar. 2026. GuruFocus rates FRA:JCR with a GF Score™ of 47/100 and a GF Value™ of €4.19 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

JCR Pharmaceuticals Co's adjusted book value per share for the three months ended in Mar. 2026 was €2.097. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.90 for the trailing ten years ended in Mar. 2026.

During the past 12 months, JCR Pharmaceuticals Co's average Cyclically Adjusted Book Growth Rate was 5.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of JCR Pharmaceuticals Co was 11.40% per year. The lowest was 4.20% per year. And the median was 8.90% per year.

As of today (2026-07-28), JCR Pharmaceuticals Co's current stock price is €2.78. JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €1.90. JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is 1.46.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of JCR Pharmaceuticals Co was 17.23. The lowest was 1.26. And the median was 7.02.


JCR Pharmaceuticals Co  (FRA:JCR) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.78/1.90
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of JCR Pharmaceuticals Co was 17.23. The lowest was 1.26. And the median was 7.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Related Terms


JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.04 1.90

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 1.96 1.93 1.86 1.90

FRA:JCR vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.


FRA:JCR
47GF Score
JCR Pharmaceuticals Co Ltd FRA:JCR
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JCR Pharmaceuticals Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.097/112.7000*112.7000
=2.097

Current CPI (Mar. 2026) = 112.7000.

JCR Pharmaceuticals Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.755 98.100 2.016
201609 1.849 98.000 2.126
201612 1.743 98.400 1.996
201703 1.808 98.100 2.077
201706 1.760 98.500 2.014
201709 1.633 98.800 1.863
201712 1.633 99.400 1.852
201803 1.700 99.200 1.931
201806 1.724 99.200 1.959
201809 1.771 99.900 1.998
201812 1.826 99.700 2.064
201903 1.983 99.700 2.242
201906 2.021 99.800 2.282
201909 2.131 100.100 2.399
201912 2.115 100.500 2.372
202003 2.208 100.300 2.481
202006 2.187 99.900 2.467
202009 2.170 99.900 2.448
202012 2.229 99.300 2.530
202103 2.399 99.900 2.706
202106 2.373 99.500 2.688
202109 2.922 100.100 3.290
202112 3.098 100.100 3.488
202203 3.148 101.100 3.509
202206 2.896 101.800 3.206
202209 2.883 103.100 3.151
202212 2.942 104.100 3.185
202303 2.921 104.400 3.153
202306 2.758 105.200 2.955
202309 2.888 106.200 3.065
202312 2.840 106.800 2.997
202403 2.764 107.200 2.906
202406 2.610 108.200 2.719
202409 2.848 108.900 2.947
202412 2.679 110.700 2.727
202503 2.411 111.100 2.446
202506 2.278 111.700 2.298
202509 2.275 112.000 2.289
202512 2.080 113.000 2.074
202603 2.097 112.700 2.097

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €1.90 mean?
JCR Pharmaceuticals Co (FRA:JCR) has a Cyclically Adjusted Book per Share of €1.90 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share too high?
JCR Pharmaceuticals Co's current Cyclically Adjusted Book per Share is €1.90. Overall, JCR Pharmaceuticals Co has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share compare to LLY and JNJ?
JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share of €1.90 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current Cyclically Adjusted Book per Share is €1.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (FRA:JCR) is currently considered Possible Value Trap. The stock's GF Value™ is €4.19, compared to a current price of €2.78 — trading 33.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is €1.90. JCR Pharmaceuticals Co's overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For JCR Pharmaceuticals Co (FRA:JCR), the current Cyclically Adjusted Book per Share is €1.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (FRA:JCR) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of €2.78 is trading 33.7% below its estimated GF Value™ of €4.19. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for FRA:JCR:

  • Cyclically Adjusted Book per Share: €1.90
  • GF Value™: €4.19 vs. price of €2.78 (33.7% below fair value)
  • GF Score™: 47/100 with 7 warning signs

No single metric tells the full story. See the FRA:JCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JCR Pharmaceuticals Co Business Description

Other Exchanges JCRRF:USA4552:Japan
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
47GF Score

Get the complete analysis for FRA:JCR

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.78
Price
€4.19
GF Value